Patients with follicular lymphoma should be treated according to baseline PET-CT findings with targeted re-biopsy
Annals of Hematology · 2025
DOI: 10.1007/s00277-025-06609-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, 2025. Verfasst von Anni Nyyssönen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Oulu, Oulu, Finland. anni.nyyssonen@student.oulu.fi. Hauptthemen laut MEDLINE: Lymphoma, Follicular, Positron Emission Tomography Computed Tomography. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Oulu.
Abstract (Originalsprache)
Although the increasing use of PET-CT has enabled improvements in staging and confirmation of a suspected histological transformation of follicular lymphoma (FL), the disease is still characterised by varied courses and outcomes. Our aim was to determine, whether diagnostic PET-CT could be effective in preventing early progression, particularly disease progression within 24 months of started therapy (POD24). Patient data of 177 grade 1-3a FL patients treated in Oulu University Hospital between years 2000 and 2020 was retrospectively reviewed. Staging of 59 patients included PET-CT before first-line treatment, when excluding two patients who were found to be primary transformed based on their PET-CT. 25 (42.4%) of the 59 patients were also re-biopsied based on the staging results. The control group consisted of 118 non-PET-CT staged patients who received systemic therapy for their disease. The use of PET-CT at the time of the diagnosis was determined by clinician based on the clinical course of the individual patient. In the PET-CT staged group four transformations were noted during follow-up and six cases of POD24 occurred. In comparison, fifteen transformations ( p = 0.306) and 18 POD24 ( p = 0.486) occurred in the reference group. A high SUVmax was indicative of worse outcomes ( p = 0.016) but survival was not improved in the re-biopsied subgroup. Diagnostic PET-CT enhanced disease course as time to progression was superior in the group of PET-CT staged patients ( p = 0.038). Our results suggest that PET-CT is a valuable diagnostic tool at baseline which may help to identify patients at risk for POD24 leading to better survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of Oulu, Oulu, Finland. anni.nyyssonen@student.oulu.fi.
- Cancer Center, Oulu University Hospital, Oulu, Finland. anni.nyyssonen@student.oulu.fi.
- Faculty of Health Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
- Department of Clinical Oncology, Kuopio University Hospital, Kuopio, Finland.
- Department of Medicine, University of Oulu, Oulu, Finland.
- Department of Radiology, Oulu University Hospital, Oulu, Finland.
Förderung
- University of Oulu
Zitieren
APA
Nyyssönen, A., Kuittinen, O., Vuolio, T., Vaattovaara, E., Rajamäki, A., Turpeenniemi-Hujanen, T., Sorigue, M., Kuitunen, H., & Kuusisto, M. E. L. (2025). Patients with follicular lymphoma should be treated according to baseline PET-CT findings with targeted re-biopsy. Annals of Hematology. https://doi.org/10.1007/s00277-025-06609-2
Vancouver
Nyyssönen A, Kuittinen O, Vuolio T, Vaattovaara E, Rajamäki A, Turpeenniemi-Hujanen T, et al. Patients with follicular lymphoma should be treated according to baseline PET-CT findings with targeted re-biopsy. Annals of Hematology. 2025. doi:10.1007/s00277-025-06609-2
BibTeX
@article{Nyyssnen2025,
author = {Nyyssönen, Anni and Kuittinen, Outi and Vuolio, Tero and Vaattovaara, Elias and Rajamäki, Aino and Turpeenniemi-Hujanen, Taina and Sorigue, Marc and Kuitunen, Hanne and Kuusisto, Milla E L},
title = {Patients with follicular lymphoma should be treated according to baseline PET-CT findings with targeted re-biopsy},
journal = {Annals of Hematology},
year = {2025},
doi = {10.1007/s00277-025-06609-2}
}
EUVIMED